Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aurocarpine is an ophthalmic pharmaceutical product developed and marketed by Aurolab, containing the active ingredient pilocarpine nitrate. As a small molecule cholinergic agonist, it targets muscarinic receptors in the eye to facilitate the drainage of aqueous humor, thereby reducing intraocular pressure. It is primarily indicated for the treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Additionally, Aurocarpine is used to induce miosis and to prevent postoperative spikes in intraocular pressure following laser eye surgery. It is available as a topical ophthalmic solution and a sterile solution for intracameral injection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aurocarpine.